InvestorsHub Logo
Post# of 179942
Next 10
Followers 105
Posts 20261
Boards Moderated 2
Alias Born 03/05/2012

Re: LeAcc post# 178188

Thursday, 08/01/2024 8:01:16 PM

Thursday, August 01, 2024 8:01:16 PM

Post# of 179942
Agree. Doesn't matter if there was insufficient data included with the IDE OR if the FDA simply ran out of time.

The thing that matters (imo) is that RDGL requested a PreSub filing to discuss matters with the FDA before filing another IDE submission. Most importantly the CEO should know for sure what is going on. But unless someone on the board has an inside source, nobody's opinion on what is going on really matters.

Obviously, everyone can have their own opinion whether it was a lack of data or insufficient time for review, but I believe only the CEO and the FDA know for sure. It should be the CEO's responsibility to inform shareholders what is going on. The FDA also knows, but they aren't talking. lol

my opinions are just that

Disclaimer: Do not rely on my projections or opinions to make a buy or sell decision. Always do your own DD.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News